Company Name: AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company.  The company is engaged in the development of medicines designed to treat, prevent and diagnose diseases that are associated with protein misfolding.  The company’s pipeline includes product candidates for Alzheimer’s disease and other neurodegenerative diseases.

Ticker Symbol: ACIU (NASDAQ)

Company Website: www.acimmune.com

Social Media: AC Immune LinkedIn

Headquarters: Lausanne, Switzerland